Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1603-7.

Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside?

Author information

1
Department of Anesthesiology, Medical College of Wisconsin, Milwaukee 53226, USA.

Abstract

A steadily increasing number of investigations demonstrate that preconditioning with volatile anesthetics attenuates the deleterious effects of myocardial ischemia and reperfusion injury by an ischemic preconditioning-like mechanism. Thus volatile anesthetics may represent the best choice for anesthesia of patients at risk for myocardial ischemia. However, factors such as old age, coexisting conditions such as diabetes mellitus and the use of oral hypoglycemic drugs or cyclooxygenase inhibitors, timing and duration of myocardial ischemia, and possible constraints of a complicated preconditioning protocol may limit the benefits of this powerful tool under clinical conditions. The purpose of this minireview is to provide a brief overview of the results of basic and clinical research on cardioprotection by volatile anesthetics.

PMID:
15072968
DOI:
10.1152/ajpheart.00963.2003
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center